Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 5Breast Neoplasms 5Colorectal Neoplasms 3Vitamin D Deficiency 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma 2Leukemia 2Thyroiditis 1Prostatic Neoplasms 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Obesity 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hypocalcemia 1Hyperthyroidism 1Goiter 1Colonic Polyps 1Colonic Neoplasms 1Bone Diseases, Metabolic 1Arthralgia 1Aflatoxin Poisoning 1Adenomatous Polyps 1Adenoma 1

Interventions

Metformin 91Clomiphene 31Letrozole 23Inositol 19Folic Acid 11Chorionic Gonadotropin 11Exercise 10High-Intensity Interval Training 9drospirenone and ethinyl estradiol combination 8Ethinyl Estradiol 8Contraceptives, Oral 8Cholecalciferol 8cetrorelix 7Tablets 7Progesterone 7Menotropins 6follitropin alfa 5Pioglitazone 5Liraglutide 5Exenatide 5Cyproterone Acetate 5Caloric Restriction 5Vitamin D 4Triptorelin Pamoate 4Surveys and Questionnaires 4Sugars 4Spironolactone 4Glycoprotein Hormones, alpha Subunit 4Fish Oils 4Estradiol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Polycystic Ovary Syndrome × Calcium Carbonate × Clear all
NCT03792984 2019-06-06

The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients

Damascus University

Phase 3 Completed
40 enrolled

Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡